Chemotherapy Room Cancer Treatment｜Kano General Hospital

Chemotherapy Room

Chemotherapy involves the use of anticancer drugs to treat cancer. While cancer treatment includes various modalities such as surgery, radiation therapy, hormone therapy, and immunotherapy, chemotherapy remains a cornerstone of treatment. Our hospital actively incorporates chemotherapy for cancer patients. Our specialists primarily administer appropriate chemotherapy regimens for various types of cancer, including gastric and colorectal cancer, in strict accordance with clinical guidelines. Each regimen—whether administered in an outpatient setting or requiring hospitalization—is reviewed by our Chemotherapy Committee to ensure careful implementation with full consideration of the patient’s Quality of Life (QOL).


For the administration of anticancer drugs, a thin tube (catheter) may be implanted into a blood vessel.	Pharmacists calculate the precise dosage tailored to each patient and mix the medications within a clean bench to ensure safety and sterility.

Chemotherapy for Unresectable Advanced or Recurrent Colorectal Cancer

We utilize treatment methods that combine multiple anticancer drugs and molecular targeted therapies. The continuation or modification of treatment is evaluated based on the drug’s effectiveness and the patient’s general physical condition.

※ You may click to increase the image’s size.

FOLFOX Regimen

A chemotherapy combination of 5-FU, Leucovorin (l-LV), and Oxaliplatin (L-OHP).

FOLFIRI Regimen

A chemotherapy combination of 5-FU, Leucovorin (l-LV), and Irinotecan (CPT-11).

Molecular Targeted Therapy: Anti-VEGF Antibody (Bevacizumab)

Bevacizumab is a therapeutic agent that works by inhibiting angiogenesis (the formation of new blood vessels). It is administered in combination with other anticancer drugs.

Side Effects of Oxaliplatin (L-OHP)-based and Irinotecan (CPT-11)-based Regimens

Side effects differ between Oxaliplatin-based and Irinotecan-based treatments. If you experience any symptoms during or after drug administration, please notify your doctor, nurse, pharmacist, or other medical staff immediately.

Case Study: Disappearance of Colorectal Cancer Liver Metastasis via FOLFOX


Before FOLFOX administration	After 3 months from FOLFOX administration

Patient: 79-year-old male with multiple liver metastases from colorectal cancer.

Result: Abdominal CT scans show that three months after starting the FOLFOX regimen, the multiple liver metastases indicated by arrows have significantly regressed.

Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer

Case Study: Disappearance of Gastric Lesion via Chemotherapy


Before S-1 plus cisplatin administration	15 months after S-1 plus cisplatin administration

Patient: 78-year-old female with Stage IV advanced gastric cancer.
Result: Gastric endoscopy results show that 15 months after starting the S-1 + Cisplatin regimen, the gastric lesion has disappeared.

Navigation About